MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

Concomitant administration of radiotherapy with cisplatin or radiotherapy with cetuximab appear to be the treatment of choice for patients with locally advanced head and neck cancer. In the present retrospective analysis, we investigated the predictive role of several biomarkers in an unselected coh...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Fountzilas, George, Kalogera-Fountzila, Anna, Lambaki, Sophia, Wirtz, Ralph M., Nikolaou, Angelos, Karayannopoulou, Georgia, Bobos, Mattheos, Kotoula, Vassiliki, Murray, Samuel, Lambropoulos, Alexandros, Aravantinos, Gerasimos, Markou, Konstantinos, Athanassiou, Eleni, Misailidou, Despina, Kalogeras, Konstantine T., Skarlos, Demosthenis
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2009
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2801452/
https://ncbi.nlm.nih.gov/pubmed/20066159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/305908
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים